Life Science Regulation and the Tidal Waves of Change


Partner Stephan Rau will be speaking on the latest developments in life sciences regulation at the ABA’s 2018 Life Sciences Conference.

Life science is amongst the fastest growing sectors both economically and technically. It is offering patients new and better treatments through new and evolving technology advancements, including more sophisticated electronic medical records (EMRs), wearable health care devices, next-generation sequencing, breakthroughs in genomics, immunotherapy, and gene therapy, and use of real-world evidence (RWE) and data analytics.

However, this all comes at a cost. The obvious are financial, but as medical devices are increasingly interconnected—via the Internet, hospital networks, other medical devices, smartphones, electronic health records, and third-party cloud solutions—there’s also an increased risk of cybersecurity attacks and infringements of the patients’ personal sphere. This session will give a perspective on the current position and then focus on anticipated legal issues and possible solutions, including data protection issues, intellectual property issues, compliance issues, and whether the regulation and increasing compliance requirements are adequate and can keep up with the tides of change.

For more information, please click here.

Mehr erfahren

Webinar / Externe Vorträge / November 11, 2020

BVCA Healthcare Sector Digital Forum

Webinar / Externe Vorträge / October 28, 2020

FDLI: Advertising and Promotion for Medical Products Conference

Virtual Event / McDermott Event / October 20 - November 17, 2020

Life Sciences Dealmaking Symposium 2020

Webinar / Externe Vorträge / October 15, 2020

Boston Biotechnology Summit